[1]GARTEN R J, DAVIS C T, RUSSELL C A, et al. Antigenic and genetic characteristics of swine-origin 2009 A(H1N1) influenza viruses circulating in humans[J]. Science, 2009, 325: 197-201. [2]WANG T T, PALESE P. Unraveling the mystery of swine influenza virus[J]. Cell, 2009, 137: 983-985. [3]WEINGARTL H M, BERHANE Y, HISANAGA T, et al. Genetic and pathobiologic characterization of pandemic H1N1 2009 influenza viruses from a naturally infected swine herd[J]. J Virol, 2010, 84(5): 2245-2256. [4]VIJAYKRISHNA D, POON L L, ZHU H C, et al. Reassortment of pandemic H1N1/2009 influenza A virus in swine[J]. Science, 2010, 328(5985): 1529. [5]SONG M S, LEE J H, PASCUA P N, et al. Evidence of human-to-swine transmission of the pandemic (H1N1) 2009 influenza virus in South Korea[J]. J Clin Microbiol, 2010, 48(9): 3204-3211. [6]CAO B, LI X W, MAO Y, et al. Clinical features of the initial cases of 2009 pandemic influenza A (H1N1) virus infection in China[J]. N Engl J Med, 2009, 361: 2507-2517. [7]HOFFMANN E, STECH J, GUAN Y, et al. Universal primer set the full-length amplification of all influenza A viruses[J].Arch Virol, 2001, 146:2275-2289. [8]NICHOLSON K G, WEBSTER R G, HAY A J. Text book of influenza [M]. Oxford: Blackwell Science, 1998. [9]BRIGHT R A, MEDINA M J, XU X Y, et al. Incidence of adamantine resistance among influenza A (H3N2) virues isolated worldwide from 1994 to 2005: a cause for concern[J]. Lancet, 2005, 366: 1175-1181. [10]KATZ J M, LU X H, TUMPEY T M, et al. Molecular correlates of influenza A H5N1 virus pathogenesis in mice[J]. J Virol, 2000, 74(22): 10807-10810. [11]SUZUKI H, SAITO R, MASUDA H, et al. Emergence of amantadine-resistant influenza A viruses: Epidemiological study[J]. J Infect Chemother, 2003, 9: 195-200. [12]SHOPE R E. Swine influenza. III. Filtration experiments and etiology[J]. J Exp Med, 1931, 54: 373-385. [13]BROWN I H. The epidemiology and evolution of influenza viruses in pigs[J]. Vet Microbiol, 2000, 74: 29-46. [14]SKEHEL J J, WILEY D C. Receptor binding and membrane fusion in virus entry: the influenza hemagglutinin[J]. Annu Rev Biochem, 2000, 69: 531-569. [15]ITO T, COUCEIRO J N, KELM S, et al. Molecular basis for the generation in pigs of influenza A viruses with pandemic potential[J]. J Virol, 1998, 72: 7367-7373. [16]NELLI R K, KUCHIPUDI S V, WHITE G A, et al. Comparative distribution of human and avian type sialic acid influenza receptors in the pig[J]. BMC Vet Res, 2010, 6: 4. [17]REID A H, JANCZEWSKI T A, LOURENS R M, et al. 1918 influenza pandemic caused by highly conserved viruses with two receptor-binding variants[J]. Emerg Infect Dis, 2003, 9: 1249-1253. [18]TUMPEY T M, MAINES T R, VAN H N, et al. A two-amino acid change in the hemagglutinin of the 1918 influenza virus abolishes transmission[J]. Science, 2007, 315(5812): 655-659. [19]UNDERWOOD P A, SKEHEL J J, WILEY D C. Receptor-binding characteristics of monoclonal antibodyselected antigenic variants of influenza virus[J]. J Virol, 1987, 61(1): 206-208. [20]OBENAUER J C, DENSON J, MEHTA P K, et al. Large-scale sequence analysis of avian influenza isolates[J]. Science, 2006, 311(5767): 1576-1580. [21]QI X, LI X, RIDER P, et al. Molecular characterization of highly pathogenic H5N1 avian influenza A viruses isolated from raccoon dogs in China[J]. PLoS ONE, 2009, 4: e4682. [22]MONTO A S. The role of antivirals in the control of influenza[J]. Vaccine, 2003, 21: 1796-1800. [23]HAY A J, WOLSTENHOLM A J, SKEHEL J J, et al. The molecular basis of the specific anti-influenza action of amantadine[J]. EMBO J, 1985, 4: 3021-3024. [24]PINTO L H, HOLSINGER L J, LAMB L A. Influenza virus M2 protein has ion channel activity[J]. Cell, 1992, 69: 517-528. [25]MCKIMM-BRESCHKIN J L. Resistance of influenza viruses to neraminidase inhibitors-A review[J]. Antivir Res, 2000, 47: 1-17. |